Global Human Chorionic Gonadotrophin (HCG) Market 2025 by Company, Regions, Type and Application, Forecast to 2031
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Human Chorionic Gonadotrophin (HCG) by Type
- 1.3.1 Overview: Global Human Chorionic Gonadotrophin (HCG) Market Size by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Global Human Chorionic Gonadotrophin (HCG) Consumption Value Market Share by Type in 2024
- 1.3.3 u-hCG
- 1.3.4 r-hCG
- 1.4 Global Human Chorionic Gonadotrophin (HCG) Market by Application
- 1.4.1 Overview: Global Human Chorionic Gonadotrophin (HCG) Market Size by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Drug
- 1.4.3 Pregnancy Test Paper
- 1.4.4 Other
- 1.5 Global Human Chorionic Gonadotrophin (HCG) Market Size & Forecast
- 1.6 Global Human Chorionic Gonadotrophin (HCG) Market Size and Forecast by Region
- 1.6.1 Global Human Chorionic Gonadotrophin (HCG) Market Size by Region: 2020 VS 2024 VS 2031
- 1.6.2 Global Human Chorionic Gonadotrophin (HCG) Market Size by Region, (2020-2031)
- 1.6.3 North America Human Chorionic Gonadotrophin (HCG) Market Size and Prospect (2020-2031)
- 1.6.4 Europe Human Chorionic Gonadotrophin (HCG) Market Size and Prospect (2020-2031)
- 1.6.5 Asia-Pacific Human Chorionic Gonadotrophin (HCG) Market Size and Prospect (2020-2031)
- 1.6.6 South America Human Chorionic Gonadotrophin (HCG) Market Size and Prospect (2020-2031)
- 1.6.7 Middle East & Africa Human Chorionic Gonadotrophin (HCG) Market Size and Prospect (2020-2031)
2 Company Profiles
- 2.1 Qingdao Kangyuan Pharmaceutical Co., Ltd.
- 2.1.1 Qingdao Kangyuan Pharmaceutical Co., Ltd. Details
- 2.1.2 Qingdao Kangyuan Pharmaceutical Co., Ltd. Major Business
- 2.1.3 Qingdao Kangyuan Pharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Product and Solutions
- 2.1.4 Qingdao Kangyuan Pharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Qingdao Kangyuan Pharmaceutical Co., Ltd. Recent Developments and Future Plans
- 2.2 Ningbo Renjian Pharmaceutical Group Co., Ltd.
- 2.2.1 Ningbo Renjian Pharmaceutical Group Co., Ltd. Details
- 2.2.2 Ningbo Renjian Pharmaceutical Group Co., Ltd. Major Business
- 2.2.3 Ningbo Renjian Pharmaceutical Group Co., Ltd. Human Chorionic Gonadotrophin (HCG) Product and Solutions
- 2.2.4 Ningbo Renjian Pharmaceutical Group Co., Ltd. Human Chorionic Gonadotrophin (HCG) Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 Ningbo Renjian Pharmaceutical Group Co., Ltd. Recent Developments and Future Plans
- 2.3 Jiangxi Haoran Biopharmaceutical Co., Ltd.
- 2.3.1 Jiangxi Haoran Biopharmaceutical Co., Ltd. Details
- 2.3.2 Jiangxi Haoran Biopharmaceutical Co., Ltd. Major Business
- 2.3.3 Jiangxi Haoran Biopharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Product and Solutions
- 2.3.4 Jiangxi Haoran Biopharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 Jiangxi Haoran Biopharmaceutical Co., Ltd. Recent Developments and Future Plans
- 2.4 Shanghai Tianwei Biopharmaceutical Co., Ltd.
- 2.4.1 Shanghai Tianwei Biopharmaceutical Co., Ltd. Details
- 2.4.2 Shanghai Tianwei Biopharmaceutical Co., Ltd. Major Business
- 2.4.3 Shanghai Tianwei Biopharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Product and Solutions
- 2.4.4 Shanghai Tianwei Biopharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 Shanghai Tianwei Biopharmaceutical Co., Ltd. Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Human Chorionic Gonadotrophin (HCG) Revenue and Share by Players (2020-2025)
- 3.2 Market Share Analysis (2024)
- 3.2.1 Market Share of Human Chorionic Gonadotrophin (HCG) by Company Revenue
- 3.2.2 Top 3 Human Chorionic Gonadotrophin (HCG) Players Market Share in 2024
- 3.2.3 Top 6 Human Chorionic Gonadotrophin (HCG) Players Market Share in 2024
- 3.3 Human Chorionic Gonadotrophin (HCG) Market: Overall Company Footprint Analysis
- 3.3.1 Human Chorionic Gonadotrophin (HCG) Market: Region Footprint
- 3.3.2 Human Chorionic Gonadotrophin (HCG) Market: Company Product Type Footprint
- 3.3.3 Human Chorionic Gonadotrophin (HCG) Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Human Chorionic Gonadotrophin (HCG) Consumption Value and Market Share by Type (2020-2025)
- 4.2 Global Human Chorionic Gonadotrophin (HCG) Market Forecast by Type (2026-2031)
5 Market Size Segment by Application
- 5.1 Global Human Chorionic Gonadotrophin (HCG) Consumption Value Market Share by Application (2020-2025)
- 5.2 Global Human Chorionic Gonadotrophin (HCG) Market Forecast by Application (2026-2031)
6 North America
- 6.1 North America Human Chorionic Gonadotrophin (HCG) Consumption Value by Type (2020-2031)
- 6.2 North America Human Chorionic Gonadotrophin (HCG) Market Size by Application (2020-2031)
- 6.3 North America Human Chorionic Gonadotrophin (HCG) Market Size by Country
- 6.3.1 North America Human Chorionic Gonadotrophin (HCG) Consumption Value by Country (2020-2031)
- 6.3.2 United States Human Chorionic Gonadotrophin (HCG) Market Size and Forecast (2020-2031)
- 6.3.3 Canada Human Chorionic Gonadotrophin (HCG) Market Size and Forecast (2020-2031)
- 6.3.4 Mexico Human Chorionic Gonadotrophin (HCG) Market Size and Forecast (2020-2031)
7 Europe
- 7.1 Europe Human Chorionic Gonadotrophin (HCG) Consumption Value by Type (2020-2031)
- 7.2 Europe Human Chorionic Gonadotrophin (HCG) Consumption Value by Application (2020-2031)
- 7.3 Europe Human Chorionic Gonadotrophin (HCG) Market Size by Country
- 7.3.1 Europe Human Chorionic Gonadotrophin (HCG) Consumption Value by Country (2020-2031)
- 7.3.2 Germany Human Chorionic Gonadotrophin (HCG) Market Size and Forecast (2020-2031)
- 7.3.3 France Human Chorionic Gonadotrophin (HCG) Market Size and Forecast (2020-2031)
- 7.3.4 United Kingdom Human Chorionic Gonadotrophin (HCG) Market Size and Forecast (2020-2031)
- 7.3.5 Russia Human Chorionic Gonadotrophin (HCG) Market Size and Forecast (2020-2031)
- 7.3.6 Italy Human Chorionic Gonadotrophin (HCG) Market Size and Forecast (2020-2031)
8 Asia-Pacific
- 8.1 Asia-Pacific Human Chorionic Gonadotrophin (HCG) Consumption Value by Type (2020-2031)
- 8.2 Asia-Pacific Human Chorionic Gonadotrophin (HCG) Consumption Value by Application (2020-2031)
- 8.3 Asia-Pacific Human Chorionic Gonadotrophin (HCG) Market Size by Region
- 8.3.1 Asia-Pacific Human Chorionic Gonadotrophin (HCG) Consumption Value by Region (2020-2031)
- 8.3.2 China Human Chorionic Gonadotrophin (HCG) Market Size and Forecast (2020-2031)
- 8.3.3 Japan Human Chorionic Gonadotrophin (HCG) Market Size and Forecast (2020-2031)
- 8.3.4 South Korea Human Chorionic Gonadotrophin (HCG) Market Size and Forecast (2020-2031)
- 8.3.5 India Human Chorionic Gonadotrophin (HCG) Market Size and Forecast (2020-2031)
- 8.3.6 Southeast Asia Human Chorionic Gonadotrophin (HCG) Market Size and Forecast (2020-2031)
- 8.3.7 Australia Human Chorionic Gonadotrophin (HCG) Market Size and Forecast (2020-2031)
9 South America
- 9.1 South America Human Chorionic Gonadotrophin (HCG) Consumption Value by Type (2020-2031)
- 9.2 South America Human Chorionic Gonadotrophin (HCG) Consumption Value by Application (2020-2031)
- 9.3 South America Human Chorionic Gonadotrophin (HCG) Market Size by Country
- 9.3.1 South America Human Chorionic Gonadotrophin (HCG) Consumption Value by Country (2020-2031)
- 9.3.2 Brazil Human Chorionic Gonadotrophin (HCG) Market Size and Forecast (2020-2031)
- 9.3.3 Argentina Human Chorionic Gonadotrophin (HCG) Market Size and Forecast (2020-2031)
10 Middle East & Africa
- 10.1 Middle East & Africa Human Chorionic Gonadotrophin (HCG) Consumption Value by Type (2020-2031)
- 10.2 Middle East & Africa Human Chorionic Gonadotrophin (HCG) Consumption Value by Application (2020-2031)
- 10.3 Middle East & Africa Human Chorionic Gonadotrophin (HCG) Market Size by Country
- 10.3.1 Middle East & Africa Human Chorionic Gonadotrophin (HCG) Consumption Value by Country (2020-2031)
- 10.3.2 Turkey Human Chorionic Gonadotrophin (HCG) Market Size and Forecast (2020-2031)
- 10.3.3 Saudi Arabia Human Chorionic Gonadotrophin (HCG) Market Size and Forecast (2020-2031)
- 10.3.4 UAE Human Chorionic Gonadotrophin (HCG) Market Size and Forecast (2020-2031)
11 Market Dynamics
- 11.1 Human Chorionic Gonadotrophin (HCG) Market Drivers
- 11.2 Human Chorionic Gonadotrophin (HCG) Market Restraints
- 11.3 Human Chorionic Gonadotrophin (HCG) Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Human Chorionic Gonadotrophin (HCG) Industry Chain
- 12.2 Human Chorionic Gonadotrophin (HCG) Upstream Analysis
- 12.3 Human Chorionic Gonadotrophin (HCG) Midstream Analysis
- 12.4 Human Chorionic Gonadotrophin (HCG) Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Human Chorionic Gonadotrophin (HCG) market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Human Chorionic Gonadotrophin (HCG) is a hormone produced during pregnancy. It is used as an indicator in pregnancy tests and can also be administered medically for various purposes.
This report is a detailed and comprehensive analysis for global Human Chorionic Gonadotrophin (HCG) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Human Chorionic Gonadotrophin (HCG) market size and forecasts, in consumption value ($ Million), 2020-2031
Global Human Chorionic Gonadotrophin (HCG) market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Human Chorionic Gonadotrophin (HCG) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Human Chorionic Gonadotrophin (HCG) market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Chorionic Gonadotrophin (HCG)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Chorionic Gonadotrophin (HCG) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Qingdao Kangyuan Pharmaceutical Co., Ltd., Ningbo Renjian Pharmaceutical Group Co., Ltd., Jiangxi Haoran Biopharmaceutical Co., Ltd., Shanghai Tianwei Biopharmaceutical Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Human Chorionic Gonadotrophin (HCG) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
u-hCG
r-hCG
Market segment by Application
Drug
Pregnancy Test Paper
Other
Market segment by players, this report covers
Qingdao Kangyuan Pharmaceutical Co., Ltd.
Ningbo Renjian Pharmaceutical Group Co., Ltd.
Jiangxi Haoran Biopharmaceutical Co., Ltd.
Shanghai Tianwei Biopharmaceutical Co., Ltd.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Human Chorionic Gonadotrophin (HCG) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Human Chorionic Gonadotrophin (HCG), with revenue, gross margin, and global market share of Human Chorionic Gonadotrophin (HCG) from 2020 to 2025.
Chapter 3, the Human Chorionic Gonadotrophin (HCG) competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Human Chorionic Gonadotrophin (HCG) market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Chorionic Gonadotrophin (HCG).
Chapter 13, to describe Human Chorionic Gonadotrophin (HCG) research findings and conclusion.